Financials
Financial year 2025
QPAC Pharma Consulting from Heist-op-den-Berg, company number BE1009225612, closed financial year 2025 with a result of € 45,346 after tax. For that financial year QPAC Pharma Consulting recorded a gross margin of € 80,712 and equity of € 48,346. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.
€ 48,346
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 45,346
Profit after tax over the fiscal year.
€ 33,564
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 45,346.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 66,298
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 81,516
€ 15,642 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 924
Supplier invoices still open on the last day of the fiscal year.
€ 13,989
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Ask about QPAC Pharma Consulting the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to QPAC Pharma Consulting?
What happened at QPAC Pharma Consulting in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 45,346. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Heist-op-den-Berg. KBO
- Bert Van Peteghem became a director. NBB
In short
Paid € 12,242 in corporate taxes since 2025.
Management
Behind QPAC Pharma Consulting is Bert Van Peteghem.
Directors
According to the 2025 annual accounts
Bert Van Peteghem
Administrator-manager
since 2024
Establishments
Establishment units
Physical locations of this company
Hollandstraat 45 box B
2220 Heist-op-den-Berg
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Heist-op-den-Berg
Same main activity (Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies), 149 active companies in Heist-op-den-Berg, largest first.
€ 1 million gross margin · 2025
€ 824,379 gross margin · 2026
€ 640,482 gross margin · 2025
€ 487,622 gross margin · 2025
€ 463,997 gross margin · 2025
€ 461,889 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Van Peteghem Bert(oprichter) 50%
- Geleyns Annik Gabriella Louisa(oprichter) 50%
Details
- Company number
- 1009.225.612
- VAT number
- BE 1009.225.612
- Registered office
- Hollandstraat 45 bus B, 2220 Heist-op-den-Berg
- Names & denominations
- QPAC Pharma Consulting · QPAC
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 May 2024
- Peppol
- Active · Active since 2 Jul 2024
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering